Skip to content

Hypotension Prediction Index (HPI) SMART-BP Trial

Hypotension Prediction Index (HPI) Software Guided Hemodynamic Management for Noncardiac Surgery Patients - Blood Pressure Trial (National PI: Kamal Maheshwari, MD, MPH)

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05105477
Enrollment
407
Registered
2021-11-03
Start date
2021-11-17
Completion date
2022-12-15
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moderate to High-risk Noncardiac Surgery

Brief summary

A multicenter, randomized comparison of intraoperative hemodynamic management with or without a protocolized strategy utilizing Hypotension Prediction Index (HPI) software guidance during moderate-to-high-risk noncardiac surgery.

Interventions

Non-protocolized standard of care to treat subjects

The AcumenTM HPI Feature Software provides the clinician with physiological insight into a patient's likelihood of trending toward a hypotensive event. The AcumenTM HPI Feature Software suite is enabled by the minimally invasive Acumen IQ sensor.

Sponsors

Edwards Lifesciences
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Signed informed consent 2. Age \>18 years 3. ASA Physical Status \> 2 4. Noncardiac surgery with expected surgery duration \> 2 hours (example include: orthopedic, spine, urology, and general surgery) 5. Planned blood pressure monitoring with an arterial line catheter; 6. General anesthesia;

Exclusion criteria

1. Participating in another interventional Trial; 2. Contraindication to arterial blood pressure monitoring; 3. Subjects with a physical site area too limited for proper Sensor placement 4. Serum creatine \> 175 μmol/L (\>2.0 mg/dL) or CKD stage \> 3A 5. Scheduled for intracranial surgery with permissive hypotension; 6. Patient who is confirmed to be pregnant and/or nursing mothers; 7. Patients with an intra-aortic balloon pump (IABP) or ventricular assist device(s); 8. Have a condition that precludes routine or tight blood pressure management such as surgeon request for relative hypotension; 9. Emergency surgery; 10. Require beach-chair positioning; 11. Scheduled for cardiac surgeries 12. Have previously participated in the SMART-BP trial.

Design outcomes

Primary

MeasureTime frameDescription
A Composite of 30-day Moderate-to-severe Perfusion Related Postoperative Complications.From post non-cardiac surgery to 30 days.A composite of 30-day moderate-to-severe perfusion related postoperative complications.

Countries

United States

Participant flow

Pre-assignment details

At the time of study termination, 407 subjects were enrolled, which included 369 pivotal subjects. Data from the pilot subjects were not analyzed for study outcomes. Only 369 subjects were pivotal subjects that were analyzed for study outcomes. The tables below display the information and results from the 369 pivotal subjects.

Participants by arm

ArmCount
HPI Arm
Acumen HPI Software Feature: The Acumen HPI Feature Software provides the clinician with physiological insight into a patient's likelihood of trending toward a hypotensive event. The Acumen HPI Feature Software suite is enabled by the minimally invasive Acumen IQ sensor.
187
Non-HPI Arm
Non-protocolized standard of care management per clinician and provider judgement
182
Total369

Baseline characteristics

CharacteristicHPI ArmNon-HPI ArmTotal
Age, Continuous63 years63 years63 years
Race/Ethnicity, Customized
African American or Black
18 Participants11 Participants29 Participants
Race/Ethnicity, Customized
American Indian or Alaska Native
2 Participants0 Participants2 Participants
Race/Ethnicity, Customized
Asian
1 Participants2 Participants3 Participants
Race/Ethnicity, Customized
Declined to identify
9 Participants6 Participants15 Participants
Race/Ethnicity, Customized
Other
7 Participants5 Participants12 Participants
Race/Ethnicity, Customized
White
150 Participants158 Participants308 Participants
Region of Enrollment
United States
187 Participants182 Participants369 Participants
Sex: Female, Male
Female
86 Participants77 Participants163 Participants
Sex: Female, Male
Male
101 Participants105 Participants206 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
3 / 1871 / 182
other
Total, other adverse events
19 / 18721 / 182
serious
Total, serious adverse events
48 / 18738 / 182

Outcome results

Primary

A Composite of 30-day Moderate-to-severe Perfusion Related Postoperative Complications.

A composite of 30-day moderate-to-severe perfusion related postoperative complications.

Time frame: From post non-cardiac surgery to 30 days.

ArmMeasureValue (NUMBER)
HPI ArmA Composite of 30-day Moderate-to-severe Perfusion Related Postoperative Complications.19 participants with post-op complications
Non-HPI ArmA Composite of 30-day Moderate-to-severe Perfusion Related Postoperative Complications.19 participants with post-op complications

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026